Economics
Ozempic-maker accuses rival of false advertising
Novo Nordisk has launched legal action accusing Eli Lilly of creating "misleading" ads, a claim its rival denies.
Novo Nordisk, the pharmaceutical company behind Wegovy and Ozempic, has initiated legal action, accusing its main competitor, Eli Lilly, of false advertising. The lawsuit claims Eli Lilly's promotional
drug market competitionpharmaceutical lawsuitfalse advertisingweight-loss drugsnovo nordiskeli lillymounjaroozempic